AU2002362579B2 - Tetrapeptide derivative crystals - Google Patents

Tetrapeptide derivative crystals Download PDF

Info

Publication number: AU2002362579B2
Authority: AU; Australia
Prior art keywords: tzt; crystal; crystals; methyl; methoxy
Prior art date: 2001-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

AU2002362579A

Other languages

English (en)

Other versions

AU2002362579A1 (en

Inventor

Arihiro Kanada

Katsuyuki Keino

Nobuyoshi Minami

Koichi Miyazaki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aska Pharmaceutical Co Ltd

Original Assignee

Teikoku Hormone Manufacturing Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-20

Filing date

2002-09-19

Publication date

2007-09-06

2002-09-19 Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd

2003-06-26 Publication of AU2002362579A1 publication Critical patent/AU2002362579A1/en

2007-09-06 Application granted granted Critical

2007-09-06 Publication of AU2002362579B2 publication Critical patent/AU2002362579B2/en

2022-09-19 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Crystallography & Structural Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU2002362579A 2001-09-20 2002-09-19 Tetrapeptide derivative crystals Ceased AU2002362579B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001286674		2001-09-20
JP2001-286674		2001-09-20
PCT/JP2002/009628 WO2003026645A1 (en)	2001-09-20	2002-09-19	Tetrapeptide derivative crystals

Publications (2)

Publication Number	Publication Date
AU2002362579A1 AU2002362579A1 (en)	2003-06-26
AU2002362579B2 true AU2002362579B2 (en)	2007-09-06

Family

ID=19109609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002362579A Ceased AU2002362579B2 (en)	2001-09-20	2002-09-19	Tetrapeptide derivative crystals

Country Status (12)

Country	Link
US (2)	US7008928B2 (ja)
EP (1)	EP1428530B1 (ja)
JP (1)	JP4060794B2 (ja)
KR (1)	KR100901096B1 (ja)
CN (2)	CN1834088A (ja)
AT (1)	ATE405578T1 (ja)
AU (1)	AU2002362579B2 (ja)
CA (1)	CA2460956C (ja)
DE (1)	DE60228459D1 (ja)
DK (1)	DK1428530T3 (ja)
ES (1)	ES2309233T3 (ja)
WO (1)	WO2003026645A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101291683B (zh) *	2004-11-24	2011-08-17	纽普罗研究有限公司	治疗疾病的方法和组合物
WO2007112453A2 (en) *	2006-03-28	2007-10-04	Neopro Labs, Llc	Methods amd compositions for treating conditions
WO2008144675A1 (en) *	2007-05-17	2008-11-27	Neopro Labs, Llc	Crystalline and amorphous forms of peptide
WO2009012472A2 (en) *	2007-07-18	2009-01-22	Neopro Labs, Llc	Methods and compositions for treating conditions
SG11201609739UA (en) *	2014-05-28	2016-12-29	Agensys Inc	Derivatives of dolaproine-dolaisoleuine peptides
EP3325497B1 (en) *	2015-07-24	2020-09-02	Arizona Board of Regents on behalf of Arizona State University	Quinstatin compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6004934A (en) *	1991-08-09	1999-12-21	Teikoku Hormone Mfg. Co., Ltd.	Tetrapeptide derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4978744A (en) *	1989-01-27	1990-12-18	Arizona Board Of Regents	Synthesis of dolastatin 10
US6034065A (en) *	1992-12-03	2000-03-07	Arizona Board Of Regents	Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10

2002
- 2002-09-19 DE DE60228459T patent/DE60228459D1/de not_active Expired - Lifetime
- 2002-09-19 CN CNA2006100043182A patent/CN1834088A/zh active Pending
- 2002-09-19 AU AU2002362579A patent/AU2002362579B2/en not_active Ceased
- 2002-09-19 CN CNB028185250A patent/CN1309413C/zh not_active Expired - Fee Related
- 2002-09-19 DK DK02799487T patent/DK1428530T3/da active
- 2002-09-19 AT AT02799487T patent/ATE405578T1/de active
- 2002-09-19 ES ES02799487T patent/ES2309233T3/es not_active Expired - Lifetime
- 2002-09-19 JP JP2003530282A patent/JP4060794B2/ja not_active Expired - Fee Related
- 2002-09-19 WO PCT/JP2002/009628 patent/WO2003026645A1/ja not_active Ceased
- 2002-09-19 CA CA2460956A patent/CA2460956C/en not_active Expired - Fee Related
- 2002-09-19 EP EP02799487A patent/EP1428530B1/en not_active Expired - Lifetime
- 2002-09-19 KR KR1020047002898A patent/KR100901096B1/ko not_active Expired - Fee Related
- 2002-09-19 US US10/490,340 patent/US7008928B2/en not_active Expired - Lifetime
2005
- 2005-07-14 US US11/180,582 patent/US7385029B2/en not_active Expired - Fee Related

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6004934A (en) *	1991-08-09	1999-12-21	Teikoku Hormone Mfg. Co., Ltd.	Tetrapeptide derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PETTIT GR et al (1994) J of Organic Chemistry 59(21):6127-6130 *

Also Published As

Publication number	Publication date
EP1428530B1 (en)	2008-08-20
CA2460956C (en)	2010-12-21
ATE405578T1 (de)	2008-09-15
CN1309413C (zh)	2007-04-11
US7008928B2 (en)	2006-03-07
EP1428530A8 (en)	2005-01-26
KR100901096B1 (ko)	2009-06-08
WO2003026645A8 (en)	2004-09-30
CN1556701A (zh)	2004-12-22
DE60228459D1 (de)	2008-10-02
WO2003026645A1 (en)	2003-04-03
ES2309233T3 (es)	2008-12-16
EP1428530A4 (en)	2005-03-30
US7385029B2 (en)	2008-06-10
KR20040036922A (ko)	2004-05-03
CA2460956A1 (en)	2003-04-03
JP4060794B2 (ja)	2008-03-12
JPWO2003026645A1 (ja)	2005-01-06
EP1428530A1 (en)	2004-06-16
DK1428530T3 (da)	2008-12-01
CN1834088A (zh)	2006-09-20
US20040254343A1 (en)	2004-12-16
US20050267041A1 (en)	2005-12-01

Publication	Publication Date	Title
KR101409651B1 (ko)	2014-06-18	시클릭 아민-1-카르복실산 에스테르 유도체 및 그것을 함유하는 약제학적 조성물
KR20010088795A (ko)	2001-09-28	ＥｔＯ2Ｃ-ＣＨ2-(Ｒ)Ｃｇｌ-Ａｚｅ-Ｐａｂ-ＯＨ의 결정질형태
AU2011334928B2 (en)	2016-09-01	Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
JP2016183193A (ja)	2016-10-20	フィダキソマイシンの固体状形態およびその調製方法
CA2180006A1 (en)	1995-08-17	Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
AU2002362579B2 (en)	2007-09-06	Tetrapeptide derivative crystals
ZA200109944B (en)	2003-03-03	A substantially crystalline form of melagatran.
CA2579119C (en)	2013-03-05	Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
CN114716441A (zh)	2022-07-08	新冠治疗药物帕罗韦德中的杂质化合物a及其制法及应用
KR102090912B1 (ko)	2020-03-18	신규한 결정형 형태의 에독사반 및 이의 제조방법
EP4431515A1 (en)	2024-09-18	Novel crystal forms of peptide boric acid compound and preparation methods therefor
EP1070083B1 (fr)	2006-01-04	Formes cristallines du 1s-[1alpha(2s,3r),9alpha]-6,10-dioxo-n- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]- amino]octahydro-6h-piridazino[1,2-a][1,2]diazepine-1-carboxamide
CN109134256B (zh)	2021-09-07	一种双醋瑞因晶体i及其制备方法与应用
CA2479888A1 (en)	2003-10-02	New crystalline forms of (2s)-n-5-¬amino(imino)methyl\|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino\|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
EP2042498A1 (en)	2009-04-01	Crystal of benzoxadiazole derivative
EP0918054B1 (en)	2002-05-29	A 1/2 sulfate of ((S)-1-((S)-2-((trans-4-aminocyclohexylmethyl) carbamoyl) pyrrolidine-1-carbonyl)-2-iso-propylthio-2-methylpropyl) carbamic acid propyl ester
EP1384708A1 (en)	2004-01-28	Process for the manufacture of form I of nolomirole hydrochloride
US20030032809A1 (en)	2003-02-13	Optimized procedures for the manufacture of paroxetine salts
JP2007302560A (ja)	2007-11-22	医薬化合物

Legal Events

Date	Code	Title	Description
2008-01-10	FGA	Letters patent sealed or granted (standard patent)
2020-04-16	MK14	Patent ceased section 143(a) (annual fees not paid) or expired